First Allied Advisory Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.76M Sell
17,124
-356
-2% -$37.2K 0.06% 324
2020
Q2
$1.77M Buy
17,480
+3,608
+26% +$323K 0.07% 312
2020
Q1
$934K Buy
13,872
+3,008
+28% +$187K 0.04% 407
2019
Q4
$601K Buy
10,864
+3,676
+51% +$174K 0.02% 644
2019
Q3
$271K Buy
+7,188
New +$279K 0.01% 951
2017
Q1
Sell
-14,624
Closed -$218K 1109
2016
Q4
$218K Buy
+14,624
New +$259K 0.01% 952
2016
Q1
Sell
-18,196
Closed -$370K 1031
2015
Q4
$370K Buy
+18,196
New +$379K 0.02% 696

Other funds holding DXCM

First Allied Advisory Services's DXCM Position: Q3 2020 in Review

First Allied Advisory Services reduced its DexCom (DXCM) stake by 2% in Q3 2020, selling an estimated $37.2K and leaving 17,124 shares worth $1.76M. The position accounts for 0.06% of the portfolio, ranked #324.

First Allied Advisory Services first reported a position in DXCM in Q4 2015 and has held it in 7 quarters since. The position peaked at $1.77M in Q2 2020. 728 funds tracked by Wall St. Rank hold DXCM as of Q3 2020.

  • First Allied Advisory Services held 17,124 shares of DexCom worth $1.76M as of Q3 2020.
  • First Allied Advisory Services sold 356 DexCom shares in Q3 2020, an estimated $37.2K.
  • DexCom made up 0.06% of First Allied Advisory Services's portfolio in Q3 2020, its #324 holding.
  • First Allied Advisory Services first reported a position in DexCom in Q4 2015 and has held it in 7 quarters since.
  • First Allied Advisory Services's DexCom position peaked at $1.77M in Q2 2020.
  • 728 funds tracked by Wall St. Rank held DexCom as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.